Search Results - "BOGNER, J. R"

Refine Results
  1. 1

    Medium‐grade proteinuria is a risk factor for incident markers of chronic kidney disease by Schrader, SY, Zeder, AJ, Hilge, R, Bogner, JR, Seybold, U

    Published in HIV medicine (01-09-2020)
    “…Objective Medium‐grade proteinuria (100–500 mg/g creatinine) is common among people living with HIV/AIDS (PLWHA) but is often undetected or ignored. This…”
    Get full text
    Journal Article
  2. 2

    Novel antibiotics: Are we still in the pre–post-antibiotic era? by Draenert, R., Seybold, U., Grützner, E., Bogner, J. R.

    Published in Infection (01-04-2015)
    “…Purpose Therapeutic efficacy and safety in infections due to multidrug-resistant bacteria can be improved by the clinical development of new compounds and…”
    Get full text
    Journal Article
  3. 3

    Clinical Outcome of HIV-Infected Patients with Discordant Virological and Immunological Response to Antiretroviral Therapy by Zoufaly, A., Heiden, M. an der, Kollan, C., Bogner, J. R., Fätkenheuer, G., Wasmuth, J. C., Stoll, M., Hamouda, O., van Lunzen, J.

    Published in The Journal of infectious diseases (01-02-2011)
    “…Background. A subgroup of human immunodeficiency virus type 1 (HIV-1)—infected patients with severe immunodeficiency show persistently low CD4+ cell counts…”
    Get full text
    Journal Article
  4. 4

    Staphylococcus aureus infection following nasal colonization: an approach to rapid risk stratification in a university healthcare system by Seybold, U, Schubert, S, Bogner, J.R, Hogardt, M

    Published in The Journal of hospital infection (01-12-2011)
    “…Summary Staphylococcus aureus carriage increases the risk of infection. Demographic and microbiological data from adult patients with nasal S. aureus carriage…”
    Get full text
    Journal Article
  5. 5

    Efficacy and safety of sequential intravenous/oral moxifloxacin vs intravenous/oral amoxicillin/clavulanate for complicated skin and skin structure infections by Vick-Fragoso, R, Hernández-Oliva, G, Cruz-Alcázar, J, Amábile-Cuevas, C. F, Arvis, P, Reimnitz, P, Bogner, J. R

    Published in Infection (01-10-2009)
    “…Background: Complicated skin and skin structure infections (cSSSIs) are an important healthcare concern worldwide, as they can be life-threatening and…”
    Get full text
    Journal Article
  6. 6
  7. 7

    MVA-nef induces HIV-1-specific polyfunctional and proliferative T-cell responses revealed by the combination of short- and long-term immune assays by Kutscher, S, Allgayer, S, Dembek, C J, Bogner, J R, Protzer, U, Goebel, F D, Erfle, V, Cosma, A

    Published in Gene therapy (01-11-2010)
    “…Several vaccination trials are evaluating the modified vaccinia virus Ankara (MVA) as a delivery vector in various clinical settings. In this paper, we present…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Stenotrophomonas maltophilia Induced Post-Cataract-Surgery Endophthalmitis: Outbreak Investigation and Clinical Courses of 26 Patients by Horster, S, Bader, L, Seybold, U, Eschler, I, Riedel, K. G, Bogner, J. R

    Published in Infection (01-04-2009)
    “…Background: Stenotrophomonas maltophilia, a microorganism which colonizes plastic material, is a rare causative agent of iatrogenic endophthalmitis. Patients…”
    Get full text
    Journal Article
  10. 10

    Mitochondrial membrane potential and apoptosis of blood mononuclear cells in untreated HIV‐1 infected patients by Sternfeld, T, Tischleder, A, Schuster, M, Bogner, JR

    Published in HIV medicine (01-09-2009)
    “…Objectives Infection with HIV leads to progressive CD4 T‐cell loss, resulting in AIDS. Apoptosis is the main mechanism for the loss of infected and bystander…”
    Get full text
    Journal Article
  11. 11

    Transmission risk behaviour at enrolment in participants in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial by Rodger, AJ, Lampe, FC, Grulich, AE, Fisher, M, Friedland, G, Phanuphak, N, Bogner, JR, Pereira, LC, Rietmeijer, C, Burman, W, Phillips, AN

    Published in HIV medicine (01-04-2015)
    “…Objectives A proportion of HIV‐positive people have condomless sex. Antiretroviral treatment (ART) reduces infectiousness, but a substantial proportion of…”
    Get full text
    Journal Article
  12. 12

    Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease: results of a multicenter study by Hentrich, M., Maretta, L., Chow, K.U., Bogner, J.R., Schürmann, D., Neuhoff, P., Jäger, H., Reichelt, D., Vogel, M., Ruhnke, M., Oette, M., Weiß, R., Rockstroh, J., Arasteh, K., Mitrou, P.

    Published in Annals of oncology (01-06-2006)
    “…The purpose of the study was to evaluate the outcome of Hodgkin's disease (HD) in patients infected with the human immunodeficiency virus (HIV) with respect to…”
    Get full text
    Journal Article
  13. 13

    Cost impact of prospective HLA-B5701-screening prior to abacavir/lamivudine fixed dose combination use in Germany by Wolf, Eva, Blankenburg, M, Bogner, J R, Becker, W, Gorriahn, D, Mueller, M C, Jaeger, H, Welte, R, Baudewig, M, Walli, R, Stoll, M

    Published in European journal of medical research (08-04-2010)
    “…Avoiding abacavir in HIV-infected patients tested positive for HLA-B*5701 reduces the risk of abacavir hypersensitivity reaction (ABC-HSR). Our aim was to…”
    Get full text
    Journal Article
  14. 14

    Severe hepatotoxicity associated with the combination of enfuvirtide and tipranavir/ritonavir : case report by JULG, Boris, BOGNER, J. R, GOEBEL, F. D

    Published in AIDS (London) (13-07-2006)
    “…Tipranavir (TPV), a new non-peptidic protease inhibitor (PI) was approved in summer 2005 after demonstration of its efficacy in patients with multiple-PI…”
    Get full text
    Journal Article
  15. 15

    Changes in lipid profiles after switching to a protease inhibitor-containing cART--unfavourable effect of fosamprenavir in obese patients by Gyalrong-Steur, Miriam, Bogner, J R, Seybold, U

    Published in European journal of medical research (24-02-2011)
    “…One focus in the medical care of HIV-infected patients today is cardiovascular risk reduction. Metabolic disturbances occur frequently in patients taking…”
    Get full text
    Journal Article
  16. 16
  17. 17

    The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI by Cozzi‐Lepri, A, Paredes, R, Phillips, AN, Clotet, B, Kjær, J, Von Wyl, V, Kronborg, G, Castagna, A, Bogner, JR, Lundgren, JD

    Published in HIV medicine (01-01-2012)
    “…Background Virological failure of first‐generation nonnucleoside reverse transcriptase inhibitors (NNRTIs) can compromise the efficacy of etravirine as a…”
    Get full text
    Journal Article
  18. 18
  19. 19

    [(13)C]Methionine breath test as a marker for hepatic mitochondrial function in HIV-infected patients by Sternfeld, T, Lorenz, A, Schmid, M, Schlamp, A, Demmelmair, H, Koletzko, B, Bogner, J R

    Published in AIDS research and human retroviruses (01-12-2009)
    “…Metabolic disturbances such as dyslipidemia, lipodystrophy syndrome, visceral obesity, hyperlactatemia, diabetes mellitus, and hepatic steatosis have been…”
    Get more information
    Journal Article
  20. 20